Line 807: |
Line 807: |
| :[[Essential thrombocythaemia]] | | :[[Essential thrombocythaemia]] |
| :[[Chronic eosinophilic leukaemia, NOS]] | | :[[Chronic eosinophilic leukaemia, NOS]] |
− | :[[Mastocytosis]] | + | :[[HAEM4:Mastocytosis]] |
| :[[Cutaneous mastocytosis]] | | :[[Cutaneous mastocytosis]] |
| :[[Systemic mastocytosis]] | | :[[Systemic mastocytosis]] |
Line 881: |
Line 881: |
| :[[Mixed phenotype acute leukaemia, B/myeloid, NOS]] 152 | | :[[Mixed phenotype acute leukaemia, B/myeloid, NOS]] 152 |
| :[[Mixed phenotype acute leukaemia, T/myeloid, NOS]] 153 | | :[[Mixed phenotype acute leukaemia, T/myeloid, NOS]] 153 |
− | :[Mixed phenotype acute leukaemia, NOS - rare types | + | :[[Mixed phenotype acute leukaemia, NOS - rare types]] |
− | :[[Other ambiguous lineage leukaemias | + | :[[Other ambiguous lineage leukaemias]] |
− | :[[Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma | + | :[[Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma]] |
| </div> | | </div> |
| </div> | | </div> |
Line 925: |
Line 925: |
| :[[Nodal marginal zone lymphoma]] | | :[[Nodal marginal zone lymphoma]] |
| :[[Follicular lymphoma]] | | :[[Follicular lymphoma]] |
− | :[Primary cutaneous follicle centre lymphoma]] | + | :[[Primary cutaneous follicle centre lymphoma]] |
| :[[Mantle cell lymphoma]] | | :[[Mantle cell lymphoma]] |
| :[[Diffuse large B-cell lymphoma (DLBCL), NOS]] | | :[[Diffuse large B-cell lymphoma (DLBCL), NOS]] |
Line 1,019: |
Line 1,019: |
| : [[Acute Lymphoblastic Leukaemia (ALL)]] | | : [[Acute Lymphoblastic Leukaemia (ALL)]] |
| : [[Acute Myeloid Leukaemia (AML)]] | | : [[Acute Myeloid Leukaemia (AML)]] |
− | ::[[Acute Megakaryoblastic Leukemia (AMKL)]] | + | ::[[HAEM5:Acute megakaryoblastic leukaemia]] |
| : [[Adrenal cortical carcinoma]] | | : [[Adrenal cortical carcinoma]] |
| : [[Anal Cancer]] | | : [[Anal Cancer]] |